Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi-221005, India.
Curr Drug Deliv. 2011 Jul;8(4):398-406. doi: 10.2174/156720111795767988.
Extensive attempts to overcome problems related to solubility of drugs for maximizing bioavailability at targeted sites in the body have been made. The issue of drug solubility appears to attract the continued interest of pharmaceutical manufacturers. In this context, nanocrystallization has emerged as an important tool. In the present review, the authors discuss the advantages of nanocrystallized drugs and examine the products available in the market as well as drugs in the pipeline using nanocrystal-based formulations, which are being developed by pharmaceutical companies for drug delivery.
人们已经做出了广泛的尝试来克服与药物在体内目标部位的生物利用度最大化相关的溶解度问题。药物溶解度问题似乎一直吸引着制药商的兴趣。在这种情况下,纳米结晶已成为一种重要的工具。在本文综述中,作者讨论了纳米结晶药物的优势,并研究了市场上现有的产品以及制药公司正在开发的基于纳米晶体制剂的药物,这些药物正在被开发用于药物输送。